Cytiva planning new Shrewsbury facility as part of expansion
Photo | Courtesy | Cytiva
Cytiva's regional offices in Marlborough
Cytiva, the rebranded GE Healthcare Life Sciences, is planning a new site in Shrewsbury as part of a worldwide expansion that includes roughly 200 additional jobs in Massachusetts.
The roughly 80,000-square-foot manufacturing building on Route 9 in Shrewsbury will make bioreactors, hardware used by drug manufacturers for growing organisms under controlled conditions needed for making biopharmaceuticals, vaccines and antibodies. The facility should be operational by the end of the year, the company said Monday.
Cytiva called Shrewsbury a natural choice for expansion given its close proximity to the company's operations in Westborough and Marlborough, in addition to having the space needed to expand manufacturing capacity.
The Shrewsbury site will join the company's existing facilities in Marlborough and Westborough. The expanded Westborough site will no longer make bioreactors but will manufacture single-use consumables products and equipment known as flow kits, Cytiva said.
The majority of new jobs added in Massachusetts will be in manufacturing and located the Shrewsbury and Westborough sites. Marlborough is one of four worldwide hubs for the company, along with others in China, Sweden and the United Kingdom.
Cytiva's newly announced expansion plans include $500 million in investment over the next five years and 1,000 new jobs worldwide.
GE Healthcare Life Sciences rebranded as Cytiva this spring. General Electric sold the division to Danaher Corp. in a $21.4-billion deal closed in late March.
The Washington, D.C., conglomerate has incorporated Cytiva within its life sciences division. Danaher most recently reported Cytiva as having nearly 7,000 employees and operations in 40 countries.
GE Healthcare Life Sciences moved its division headquarters to Marlborough in 2016, taking up part of a former Digital Equipment Corp. office it now shares with Quest Diagnostics and regional offices of Whole Foods Market. The 210,000-square-foot facility was a $27-million investment for the company, the WBJ reported at the time.
Company officials said then the move from New Jersey was done in part to better leverage GE's 2012 acquisition of Xcellerex, a Marlborough company specializing in single-use bioreactors.
WBJ Web Partners
Most Recent
Most Recent
0 Comments